BEAT (Heartbeam, Inc. Common Stock) Stock Analysis - Analyst Ratings

Heartbeam, Inc. Common Stock (BEAT) is a publicly traded Healthcare sector company. As of May 21, 2026, BEAT trades at $0.92 with a market cap of $53.25M and a P/E ratio of -1.51. BEAT moved +1.75% today. Year to date, BEAT is -66.51%; over the trailing twelve months it is -44.72%. Its 52-week range spans $0.54 to $4.00. Analyst consensus is strong buy with an average price target of $4.50. Rallies surfaces BEAT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate BEAT?

6 analysts cover BEAT: 0 strong buy, 5 buy, 1 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $4.50.

BEAT Key Metrics

Key financial metrics for BEAT
MetricValue
Price$0.92
Market Cap$53.25M
P/E Ratio-1.51
EPS$-0.62
Dividend Yield0.00%
52-Week High$4.00
52-Week Low$0.54
Volume417.05K
Avg Volume0
Revenue (TTM)$0
Net Income$-21.02M
Gross Margin0.00%

BEAT Analyst Consensus

6 analysts cover BEAT: 0 strong buy, 5 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $4.50.

Latest BEAT News

Recent BEAT Insider Trades

  • Ferrari Richard bought 57.50K (~$46.00K) on Apr 16, 2026.
  • Cruickshank Tim bought 31.25K (~$25.00K) on Apr 16, 2026.
  • Elfrink Willem bought 187.50K (~$150.00K) on Apr 16, 2026.

Common questions about BEAT

What do analysts rate BEAT?
6 analysts cover BEAT: 0 strong buy, 5 buy, 1 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $4.50.
Does Rallies show BEAT price targets?
Yes. Rallies tracks BEAT analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is BEAT research on Rallies investment advice?
No. Rallies provides research, data, and educational context for BEAT. It does not provide personalized investment advice.
BEAT

BEAT